Good evening. This snapshot of stories and roundup is recommended just for you, based on your interests and reading history. | | | | Marty Makary at an event on health care affordability at the White House in April. (Mark Schiefelbein/AP) | | | | | | |  What to know The White House plans to replace FDA Commissioner Marty Makary after internal turmoil and criticism, according to individuals familiar with the matter who spoke on the condition of anonymity to discuss internal decisions. Makary, confirmed in March 2025, faced backlash over drug approvals and vaccine policies. The administration is considering broader FDA changes but has not decided on an acting leader. The White House did not comment on Makary’s status or FDA changes. Summary is AI-generated, newsroom-reviewed. | | | | | How was today's newsletter? | | | | | | | | |
Have a question? Ask the Post AI to learn more 
